TFF2 and migraine disorder: Experimental studies on migraine have demonstrated that the activation of the trigeminovascular system with the release of vasoactive neuropeptides, such as substance P (SP), calcitonin gene-related peptide (CGRP), and neurokinin A, causes vasodilation of the dura with the release of pro-inflammatory factors and the resultant neurogenic inflammation (15).